药明康德

药明康德

制药业

Shanghai,Shanghai 72,184 位关注者

The global pharmaceutical and medical device open-access capability and technology platform

关于我们

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the third consecutive year in 2023 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."

所属行业
制药业
规模
超过 10,001 人
总部
Shanghai,Shanghai
类型
上市公司
创立
2000
领域
Drug Discovery、Bioanalytical、Lab Testing、Clinical and Regulatory、API Development and Manufacturing、Drug Development、Biological Reagents、Biologics、Medical Device、Chemistry、Toxicology、Cell and Gene Therapy和Contract Research Organization

地点

药明康德员工

动态

  • 查看药明康德的公司主页,图片

    72,184 位关注者

    Last week, the 2025 WuXi Global Forum brought together thousands of leaders, innovators, and visionaries from around the world to share ideas and spark meaningful collaborations. Today, we’re excited to share the digital premiere of the event, including highlights from the opening plenary, with over 120 executive roundtables led by C-Suite leaders. Join us in celebrating the progress we’ve made and the shared journey that unites us all in transforming patients’ lives.   Every Innovation Story Matters: https://lnkd.in/dcYz_nEc

  • 查看药明康德的公司主页,图片

    72,184 位关注者

    Thank you to our friends and colleagues who joined us yesterday for our 13th annual WuXi Global Forum at #JPM2025. Your presence and engagement reflect the true essence of our industry: a shared journey of knowledge, collaboration, and advancement for patients. We are especially grateful to our distinguished panelists and executive roundtable hosts for sharing their insights and expertise. Your contributions continue to push the boundaries of innovation and collaboration within the global healthcare community. It was inspiring to hear witness the collective wisdom, forward-thinking ideas, and partnerships that emerged during the Forum’s more than 120 executive roundtables. Together, we are advancing new solutions that will shape the future of healthcare.

  • 查看药明康德的公司主页,图片

    72,184 位关注者

    We're pleased to announce that WuXi AppTec has joined the Pharmaceutical Supply Chain Initiative (#PSCI) as a Supplier Partner! This underscores the company’s enduring commitment to responsible business practices and supply chain resilience.   By adhering to PSCI standards and enhancing our value chain management, we remain dedicated to supporting our customers in delivering innovative new therapies to #patients, working together towards a healthier and more sustainable future.   Read more: https://lnkd.in/ejzC-esU

    • that WuXi AppTec has joined the Pharmaceutical Supply Chain Initiative (#PSCI) as a Supplier Partner
  • 查看药明康德的公司主页,图片

    72,184 位关注者

    As we welcome 2025, we are filled with gratitude for our incredible customers, partners, and the entire #healthcare community. Your trust, support, and collaboration are the driving force behind our progress.   We are excited to continue our work, enabling those working to innovate and develop treatments for patients around the world. May 2025 bring you health, happiness, and renewed inspiration. We can’t wait to achieve more, together.

    • 2025 Happy New Year
  • 查看药明康德的公司主页,图片

    72,184 位关注者

    We are delighted to share that WuXi AppTec has been recognized by S&P Dow Jones Indices in Sustainability (DJSI) for the fourth consecutive year! We are featured in both the 2024 DJSI World and the 2024 DJSI Emerging Markets. This is an acknowledgment of our ongoing commitment to #sustainability and the integration of responsible practices across our operations. We will continue to emphasize our #ESG commitment while supporting our customers who develop and deliver innovative new therapies to patients worldwide.  Read more: https://lnkd.in/eqjyZn33

    • WuXi AppTec’s Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year
  • 查看药明康德的公司主页,图片

    72,184 位关注者

    As we celebrate the holiday season, we are deeply grateful for our customers, partners, and colleagues around the globe. Your trust, collaboration, and unwavering support have been the foundation of everything we’ve achieved together in 2024.   This season reminds us of the values we cherish most—connection, innovation, and the shared commitment to transforming lives. Through our unique #CRDMO model and the passion of our global team, we’ve continued to enable our partners to bring hope to patients in need.   From all of us at WuXi AppTec, we wish you and your loved ones a joyful holiday season filled with warmth, peace, and togetherness. Here’s to another year of making a difference, together.

    • 该图片无替代文字
  • 查看药明康德的公司主页,图片

    72,184 位关注者

    This December marks WuXi AppTec’s 24th anniversary! For 24 years, our belief that “every drug can be made and every disease can be treated” has continued to inspire us as we look to the future with determination and optimism. Starting from a single laboratory, we have grown into a global enterprise with 32 R&D and manufacturing sites worldwide, dedicated to advancing breakthroughs in life-sciences. Thank you to our customers, partners, and global teams - your commitment to our mission of enabling transformative solutions has been the heartbeat of our success. Together, we’re not just imagining a healthier world - we are building it.

    • WuXi AppTec’s 24th anniversary
  • 查看药明康德的公司主页,图片

    72,184 位关注者

    As we mark Thanksgiving in the United States, we wanted to extend our gratitude to our global teams for their dedication and to our customers worldwide for their continued trust and support. Together, we are driving innovation, bringing hope and advancements to patients, striving towards a healthier world. This season is a reminder of our shared goals and the positive impact we make together.   Happy #Thanksgiving to those in the United States!

    • Happy Thanksgiving 2024 from WuXi AppTec

关联主页

相似主页